Direct Flow Taps Lemaitre To Lead Face Off With TAVR Giants
This article was originally published in The Gray Sheet
Direct Flow Medical hopes it May 7 appointment of Daniel Lemaitre as CEO will elevate its competitive game against larger players in the transcatheter aortic valve replacement market.
You may also be interested in...
EnteroMedics founder and CEO to retire, Direct Flow Medical appoints VP, regulatory and clinical affairs, Veracyte names chief medical officer, and more personnel updates from around the industry.
Victoria Carr-Brendel, who was running Boston Scientific’s Bayer Interventional business, is the new CEO of transcatheter aortic valve company JenaValve. TAVR startup competitor, Direct Flow Medical, also recently hired a new CEO with large-company medtech pedigree.
Medtronic will enter the high-growth, minimally invasive aortic heart valve market through two acquisitions worth more than $1 billion